TOVX Theriva Biologics, Inc.

Fundamentals / CIK 0000894158 / USD

Theriva Biologics, Inc. reported $31.56M in total assets and a net loss of $10.24M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TOVX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$25.48MFY 2016 Net Income: -$27.25M2016FY 2017 Net Income: -$15.17M2017FY 2018 Net Income: -$13.37M2018FY 2019 Net Income: -$15.30M2019FY 2020 Net Income: -$10.04M2020FY 2021 Net Income: -$14.27M2021FY 2022 Net Income: -$19.68M2022FY 2023 Net Income: -$18.35M2023FY 2024 Net Income: -$25.65M2024FY 2025 Net Income: -$25.25M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $8.60M $12.03M $14.31M $11.72M $7.80M $5.13M $11.08M $11.84M $18.78M $29.11M
Total Operating Expenses $24.05M $26.35M $21.43M $21.58M $14.27M $10.16M $15.66M $17.57M $26.25M $39.25M
Operating Income -$24.05M -$26.35M -$21.43M -$21.58M -$14.27M -$10.16M -$15.66M -$17.57M -$26.25M -$39.25M
EBITDA -$23.94M -$26.21M -$21.30M -$21.50M -$14.19M -$9.96M -$15.42M -$17.30M -$26.01M -$39.09M
Interest Income $287K $697K $1.44M $512K $6.0K $44K $283K $67K $21K $37K
Interest Expense $61K $6.0K -- -- -- -- -- -- -- --
Income Before Tax -$23.74M -$25.65M -$19.99M -$21.11M -$14.27M -- -- -- -- --
Income Tax Expense -- $0 -$1.64M -$1.43M $0 $0 $0 $0 $0 $0
Net Income -$25.25M -$25.65M -$18.35M -$19.68M -$14.27M -$10.04M -$15.30M -$13.37M -$15.17M -$27.25M
Basic EPS -$2.08 -$19.03 -$28.48 -$32.75 -$47.50 -$16.50 -$24.50 -$101.50 -$155.75 -$10,389.20
Diluted EPS -$2.08 -$19.03 -$28.48 -$32.75 -$47.50 -$16.50 -$24.50 -$101.50 -$155.75 -$10,389.20
Basic Shares Outstanding 12.1M 1.3M 644.3K 613.1K 487.5K 760.5K 657.5K 249.3K 142.1K 2.6K
Diluted Shares Outstanding 12.1M 1.3M 644.3K 613.1K 487.5K 760.5K 657.5K 249.3K 142.1K 2.6K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $300K -- -- -- -- --
Research & Development $612K $1.27M $355K $1.13M $2.55M $1.95M $2.97M $2.89M
Total Operating Expenses $1.53M $3.29M $2.43M $2.06M $4.44M $13.13M $4.42M $4.58M
Operating Income -$1.53M -$3.29M -$2.13M -$2.06M -$4.44M -$13.13M -$4.42M -$4.58M
EBITDA -$1.51M -$3.27M -$2.10M -$2.04M -$4.41M -$13.11M -$4.39M -$4.55M
Interest Income $64K $79K $82K $72K $65K $54K $96K $138K
Interest Expense $16K $17K $16K $16K $16K $16K $12K --
Income Before Tax -$1.47M -$3.22M -$2.04M -$2.00M -$4.36M -$13.06M -$4.32M -$4.45M
Net Income -$1.47M -$3.22M -$2.04M -$3.51M -$4.36M -$13.06M -$4.32M -$4.45M
Basic EPS -$0.03 -$0.07 -$0.05 -- -$0.45 -$1.93 -$1.55 --
Diluted EPS -$0.03 -$0.07 -$0.05 -- -$0.45 -$1.93 -$1.55 --
Basic Shares Outstanding 45.9M 45.9M 41.1M -- 9.7M 6.8M 2.8M --
Diluted Shares Outstanding 45.9M 45.9M 41.1M -- 9.7M 6.8M 2.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Sep 30 Jun 30 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $13.06M $11.61M $23.18M $41.79M $50.49M $52.27M $67.33M $6.23M $15.04M $28.92M
Cash & Short-Term Investments $13.06M $11.61M $23.18M $41.79M $50.49M $52.27M $67.33M $6.23M $15.04M $28.92M
Total Current Assets $17.47M $16.28M $27.40M $45.52M $52.73M $54.89M $68.86M $7.93M $16.43M $29.51M
Property, Plant & Equipment, Net $222K $270K $422K $345K $262K $285K $101K $174K $367K $607K
Goodwill -- $0 $5.70M $5.53M $5.22M $6.22M $0 -- -- --
Intangible Assets $19.62M $17.36M $19.75M $19.15M $17.54M $17.84M -- -- -- --
Total Non-Current Assets $20.77M $19.07M $27.82M $26.34M $24.38M $25.75M $1.51M $476K $809K $630K
Total Assets $38.24M $35.35M $55.22M $71.86M $77.11M $80.64M $70.36M $8.41M $17.23M $30.14M
Accounts Payable $1.01M $859K $770K $915K $770K $1.00M $524K $886K $2.31M $1.03M
Short-Term Debt -- -- $63K $57K $52K $56K -- -- -- --
Deferred Revenue (Current) -- -- $906K -- -- -- -- -- -- --
Total Current Liabilities $10.01M $7.58M $6.74M $7.06M $12.32M $12.42M $3.55M $2.97M $5.28M $3.38M
Long-Term Debt $1.67M $92K -- -- -- -- -- -- -- --
Deferred Revenue (Non-Current) -- -- $906K -- -- -- -- -- -- --
Total Non-Current Liabilities $12.84M $8.70M $8.78M $10.24M $5.67M $6.00M $1.40M $186K $473K $302K
Total Liabilities $22.86M $16.29M $15.52M $17.30M $17.99M $18.42M $4.96M $3.15M $5.75M $3.69M
Total Debt (incl. Leases) $2.57M $1.50M $1.99M $1.46M $1.45M $1.48M $1.53M $473K $722K --
Common Stock $34K $3.0K $1.0K $16K $16K $16K $13K $29K $17K $15K
Retained Earnings -$358.7M -$335.0M -$309.3M -$291.0M -$284.5M -$280.0M -$271.3M -$248.1M -$235.5M -$219.5M
Accumulated Other Comp. Income $755K -$1.18M $32K -$679K -$2.73M -$1.26M -- -- -- --
Total Stockholders' Equity -- -- -- -- $56.39M $62.22M $65.41M -$4.77M $1.82M $17.07M
Total Equity $15.38M $19.07M $36.96M $51.83M $56.39M $62.22M $65.41M -$7.54M -$1.06M $14.16M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $8.47M $11.34M $14.43M $13.06M $7.53M $12.12M $10.01M $11.61M
Cash & Short-Term Investments $8.47M $11.34M $14.43M $13.06M $7.53M $12.12M $10.01M $11.61M
Total Current Assets $10.62M $13.67M $16.76M $17.47M $9.90M $14.74M $12.48M $16.28M
Property, Plant & Equipment, Net $155K $173K $194K $222K $249K $258K $253K $270K
Goodwill -- -- -- -- -- -- -- $0
Intangible Assets $18.96M $19.06M $19.23M $19.62M $19.61M $19.62M $18.08M $17.36M
Total Non-Current Assets $20.94M $21.19M $21.49M $20.77M $20.93M $21.09M $19.68M $19.07M
Total Assets $31.56M $34.86M $38.25M $38.24M $30.84M $35.83M $32.16M $35.35M
Accounts Payable $467K $984K $608K $1.01M $795K $607K $437K $859K
Total Current Liabilities $8.78M $12.11M $10.26M $10.01M $11.00M $12.39M $8.15M $7.58M
Long-Term Debt -- -- -- $1.67M -- -- -- $92K
Total Non-Current Liabilities $12.03M $10.56M $12.59M $12.84M $13.10M $12.81M $8.52M $8.70M
Total Liabilities $20.81M $22.67M $22.85M $22.86M $24.10M $25.21M $16.66M $16.29M
Total Debt (incl. Leases) $1.77M $1.90M $2.03M $2.57M $1.05M $1.20M $1.30M $1.50M
Common Stock $45K $45K $45K $34K $9.0K $8.0K $3.0K $3.0K
Retained Earnings -$365.4M -$364.0M -$360.8M -$358.7M -$356.7M -$352.4M -$339.3M -$335.0M
Accumulated Other Comp. Income $140K $247K $377K $755K $763K $793K -$524K -$1.18M
Total Equity $10.75M $12.19M $15.40M $15.38M $6.74M $10.62M $15.50M $19.07M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$23.74M -$25.65M -$18.35M -$19.68M -$14.27M -$10.12M -$15.38M -$13.42M -$15.49M -$27.80M
Depreciation & Amortization $108K $137K $135K $85K $87K $201K $240K $272K $245K $157K
Stock-Based Compensation $654K $671K $552K $475K $416K $350K $340K $2.07M $3.41M $4.01M
Change in Payables $69K $123K -$157K -$385K -$363K -$1.43M $1.28M -$987K $27K -$2.42M
Operating Cash Flow -$16.67M -$16.94M -$19.00M -$19.08M -$12.89M -$12.17M -$13.87M -$17.28M -$20.20M -$27.90M
Capital Expenditure -$35K -$1.0K -$202K -$116K -$14K -$9.0K $0 -$7.0K -$212K -$569K
Free Cash Flow -$16.70M -$16.94M -$19.20M -$19.20M -$12.90M -$12.18M -$13.87M -$17.29M -$20.42M -$28.47M
Investing Cash Flow -$35K -$1.0K -$202K -$4.40M -$14K -$9.0K $0 -$7.0K -$212K -$569K
Common Stock Issued -- -- -- $0 $65.96M $3.36M $0 $12.17M $0 $25.00M
Share Repurchases -- -- $0 -$288K $0 -- -- -- -- --
Financing Cash Flow $18.19M $5.50M $625K -$1.93M $74.00M $3.36M $0 $29.09M $18.48M $26.71M
Net Change in Cash $1.40M -$11.57M -$18.61M -$25.41M $61.10M -$8.82M -$13.87M $11.80M -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$1.47M -$3.22M -$2.04M -$2.00M -$4.36M -$13.06M -$4.32M -$4.45M
Depreciation & Amortization $22K $24K $24K $27K $28K $27K $26K $27K
Stock-Based Compensation $144K $135K $135K $153K $228K $173K $100K $162K
Change in Payables -$524K $389K -$397K $209K $161K $139K -$440K $144K
Operating Cash Flow -$2.86M -$3.08M -$2.46M -$2.88M -$4.32M -$4.71M -$4.76M -$4.69M
Financing Cash Flow -$6.0K -$14K $3.87M $8.46M -$148K $6.81M $3.07M --
Net Change in Cash -$2.86M -$3.10M $1.37M $5.53M -$4.59M $2.05M -$1.59M -$4.81M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -- -- -- -- -21.8% -- -840.4% -78.3% -- -708.8%
Return on Assets (ROA) -66.0% -72.6% -33.2% -27.4% -20.3% -119.4% -88.8% -44.3% -80.5% -121.1%
Current Ratio 1.74x 2.15x 4.07x 6.45x 19.37x 2.67x 3.11x 8.72x 1.83x 1.09x
Quick Ratio 1.30x 1.53x 3.44x 5.92x 18.94x 2.10x 2.85x 8.55x 1.75x 0.96x
Debt to Equity -- -- -- -- 0.02x -- 0.40x -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Assets (ROA) -32.4% -37.7% -60.1% -66.0% -84.9% -82.5% -77.2% -72.6%
Current Ratio 1.21x 1.13x 1.63x 1.74x 0.90x 1.19x 1.53x 2.15x
Quick Ratio 0.97x 0.94x 1.41x 1.30x 0.68x 0.98x 1.23x 1.53x
Source: SEC EDGAR CompanyFacts (CIK 0000894158) · from June 30, 2010 Data through September 30, 2026 · synced Nov 21, 2026, 05:08 UTC · Open in terminal